Editorial Policy

Editorial Notice

AACE Endocrine AI is published by Conexiant in partnership with the American Association of Clinical Endocrinology (AACE). The content reflects the perspectives of individual authors and contributors and does not necessarily represent the official positions of Conexiant or AACE. References to specific products, technologies, therapies, or organizations are provided for informational purposes only and should not be interpreted as endorsements. Although every effort is made to ensure accuracy and relevance, Conexiant and AACE disclaim responsibility for any errors, omissions, or outcomes associated with the use of information presented in this publication.

AI Policy

AACE Endocrine AI is committed to providing clinically relevant, accurate, and ethically developed content for endocrinology professionals. As a platform focused on the intersection of artificial intelligence and endocrine care, we recognize both the value and the limitations of AI technologies in medical publishing.

AI tools may be used to support aspects of content creation, including drafting, summarization, and editing. However, their use must be responsible, transparent, and consistent with our standards for scientific rigor and editorial integrity. AI is intended to augment—not replace—clinical expertise, critical thinking, and human judgment.

All published content must be attributed to a human author who assumes full responsibility for its accuracy and interpretation. In all cases, material must undergo thorough human review to ensure it reflects current evidence, avoids bias, and meets the expectations of a clinical audience.

This policy applies to all contributors, including clinicians, researchers, and members of the editorial team. As the capabilities and use of AI continue to evolve, AACE Endocrine AI will periodically update its policies to align with best practices in medical publishing and digital ethics.